A Secret Weapon For "3
These trials confirmed clinically major pharmacokinetic interactions [seven] characterised by a decrease from the clearance of the anticancer drug and as a result elevated exposure. The interpretation of subsequent stage II and III medical trials was sophisticated as it was impossible to administer a similar dose of chemotherapy within the presence